CD8A and metastatic neoplasm: For example, analysis of the aggregation of TSTs in metastatic lesions of patients with CRC after chemotherapy was performed based on the DP CD8+ T cell subpopulation, and this reaffirmed that DP CD8+ T cells were a cell subpopulation capable of reacting to mutant antigens in primary and metastatic tumors (88).